Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 4
1964 15
1965 24
1966 30
1967 19
1968 29
1969 38
1970 38
1971 43
1972 49
1973 39
1974 60
1975 55
1976 59
1977 67
1978 62
1979 66
1980 83
1981 64
1982 78
1983 46
1984 73
1985 59
1986 50
1987 68
1988 41
1989 57
1990 60
1991 58
1992 65
1993 61
1994 60
1995 50
1996 56
1997 69
1998 54
1999 50
2000 70
2001 71
2002 56
2003 69
2004 53
2005 61
2006 75
2007 73
2008 67
2009 77
2010 76
2011 80
2012 63
2013 78
2014 62
2015 67
2016 50
2017 56
2018 63
2019 64
2020 64
2021 45
Text availability
Article attribute
Article type
Publication date

Search Results

3,182 results
Results by year
Filters applied: . Clear all
Page 1
Safety of nortriptyline at equivalent therapeutic doses for smoking cessation: a systematic review and meta-analysis.
Dhippayom T, Chaiyakunapruk N, Jongchansittho T. Dhippayom T, et al. Drug Saf. 2011 Mar 1;34(3):199-210. doi: 10.2165/11585950-000000000-00000. Drug Saf. 2011. PMID: 21332244 Review.
BACKGROUND: The limited use of nortriptyline for smoking cessation is likely due to concerns about its serious adverse effects. OBJECTIVE: To examine the safety of nortriptyline at doses equivalent to those used in aiding smoking cessation. ...
BACKGROUND: The limited use of nortriptyline for smoking cessation is likely due to concerns about its serious adverse effects. OBJEC …
Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis.
Wagena EJ, Knipschild P, Zeegers MP. Wagena EJ, et al. Addiction. 2005 Mar;100(3):317-26. doi: 10.1111/j.1360-0443.2005.00998.x. Addiction. 2005. PMID: 15733245 Review.
The difference in efficacy between nortriptyline and placebo was highest in the first months after the target quit date. ...Furthermore, the use of nortriptyline for smoking cessation is well tolerated and safe. As a result, we believe health care professionals shou …
The difference in efficacy between nortriptyline and placebo was highest in the first months after the target quit date. ...Furthermo …
Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
Nordin C, Bertilsson L. Nordin C, et al. Clin Pharmacokinet. 1995 Jan;28(1):26-40. doi: 10.2165/00003088-199528010-00004. Clin Pharmacokinet. 1995. PMID: 7712660 Review.
In an ultrarapid hydroxylator of nortriptyline treated with very high doses of nortriptyline, the plasma concentration of unconjugated 10-OH-NT was very high without any sign of anticholinergic adverse effects. These results show that hydroxymetabolites of nortri
In an ultrarapid hydroxylator of nortriptyline treated with very high doses of nortriptyline, the plasma concentration of unco …
Relationships among nortriptyline, 10-OH(E)nortriptyline, and 10-OH(Z)nortriptyline steady-state plasma levels and nortriptyline dosage.
Lukey BJ, Jones DR, Wright JH, Hurst HE. Lukey BJ, et al. Ther Drug Monit. 1989;11(3):221-7. doi: 10.1097/00007691-198905000-00001. Ther Drug Monit. 1989. PMID: 2728080
Concentrations of 10-OH(E)nortriptyline did not correlate well with corresponding 10-OH(Z)nortriptyline concentrations (r2 = 0.236, p less than 0.05). Neither dose/body weight nor obesity were good predictors of individual concentrations of nortriptyline, 10- …
Concentrations of 10-OH(E)nortriptyline did not correlate well with corresponding 10-OH(Z)nortriptyline concentrations (r2 = 0 …
The Effectiveness of Nortriptyline and Tolerability of Side Effects in Neurogenic Cough Patients.
Song SA, Choksawad K, Franco RA Jr. Song SA, et al. Ann Otol Rhinol Laryngol. 2021 Jul;130(7):781-787. doi: 10.1177/0003489420970234. Epub 2020 Nov 20. Ann Otol Rhinol Laryngol. 2021. PMID: 33218281
OBJECTIVE: To determine the effectiveness of nortriptyline and tolerability of side effects in the treatment of neurogenic cough. ...Although 38% experienced side effects, the majority of patients continued nortriptyline despite side effects. LEVEL OF EVIDENCE: 4... …
OBJECTIVE: To determine the effectiveness of nortriptyline and tolerability of side effects in the treatment of neurogenic cough. ... …
Imipramine equivalents.
Kantor SJ. Kantor SJ. J Clin Psychiatry. 1990 Jun;51(6):257. J Clin Psychiatry. 1990. PMID: 2189871 Clinical Trial. No abstract available.
Valproate/nortriptyline interaction.
Fu C, Katzman M, Goldbloom DS. Fu C, et al. J Clin Psychopharmacol. 1994 Jun;14(3):205-6. doi: 10.1097/00004714-199406000-00009. J Clin Psychopharmacol. 1994. PMID: 8027418 No abstract available.
Drug-induced Creutzfeldt-Jakob like syndrome.
Finelli PF. Finelli PF. J Psychiatry Neurosci. 1992 Sep;17(3):103-5. J Psychiatry Neurosci. 1992. PMID: 1390620 Free PMC article. Review.
A patient with progressive neurological deterioration characterized by cognitive impairment, myoclonus, Parkinson's syndrome, an abnormal electroencephalogram and fasciculations was considered for brain biopsy for suspected Creutzfeldt-Jakob disease. Complete clinical reco …
A patient with progressive neurological deterioration characterized by cognitive impairment, myoclonus, Parkinson's syndrome, an abno …
Fluoxetine and nortriptyline combination therapy.
Schraml F, Benedetti G, Hoyle K, Clayton A. Schraml F, et al. Am J Psychiatry. 1989 Dec;146(12):1636-7. Am J Psychiatry. 1989. PMID: 2589560 No abstract available.
3,182 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page